Suven Pharmaceuticals Ltd - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
08 Sep 2024
An update, in reference to our previous intimation dated July 13, 2024, concerning the inspection conducted by the US FDA at the formulation manufacturing facility of Casper Pharma Private Limited, Wholly Owned Subsidiary of the Comapny
Source:
BSE India